ACAD vs AKTX
ACADIA Pharmaceuticals Inc. · Akari Therapeutics, Plc
Relative return (rebased to 100)
Key stats
| Metric | ACAD | AKTX |
|---|---|---|
| Price | $28.38 | $7.00 |
| Market Cap | $4.86B | $640.97B |
| P/E | 12.43 | — |
| P/B | 3.89 | 44573.65 |
| P/S | 4.54 | 1742346.13 |
| ROE | 31.3% | -120.3% |
| Net Margin | 36.5% | -4702.1% |
| Gross Margin | 63.9% | — |
| Revenue Growth | 11.9% | -39.5% |
| Dividend Yield | — | — |
| EPS | $2.28 | -$0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.